Gluconorm-G 4 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 4 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake by muscles. The prolonged-release formulation ensures a steady plasma concentration, improving glycemic control while minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Gluconorm-G 4 Forte is prescribed as an adjunct to diet and exercise to achieve optimal blood sugar regulation in patients inadequately controlled on monotherapy or lifestyle modifications alone. It is essential to monitor renal function prior to and during treatment due to the risk of lactic acidosis associated with metformin. Caution is advised in patients with hepatic impairment, cardiovascular disease, or conditions predisposing to hypoxia. Regular blood glucose monitoring is recommended to adjust dosage and prevent hypoglycemia. This combination therapy offers a complementary mechanism of action, providing effective glycemic control with improved patient compliance. Consultation with a healthcare professional is necessary before initiating therapy to ensure suitability and safety.